J
John D. Parker
Researcher at University of Toronto
Publications - 202
Citations - 10437
John D. Parker is an academic researcher from University of Toronto. The author has contributed to research in topics: Heart failure & Blood pressure. The author has an hindex of 52, co-authored 200 publications receiving 9787 citations. Previous affiliations of John D. Parker include University Health Network & University of Mainz.
Papers
More filters
Journal ArticleDOI
Risk Factors for Central and Obstructive Sleep Apnea in 450 Men And Women with Congestive Heart Failure
TL;DR: It is concluded that historical information, supplemented by a few simple laboratory tests may enable physicians to risk stratify CHF patients for the presence of CSA or OSA, and the need for diagnostic polysomnography for such patients.
Journal ArticleDOI
Influence of obstructive sleep apnea on mortality in patients with heart failure.
Hanqiao Wang,John D. Parker,Gary E. Newton,John S. Floras,S. Mak,Kuo-Liang Chiu,Pimon Ruttanaumpawan,George Tomlinson,T. Douglas Bradley,T. Douglas Bradley,T. Douglas Bradley +10 more
TL;DR: In patients with HF, untreated OSA is associated with an increased risk of death independently of confounding factors, and this study was the first to report this effect.
Journal ArticleDOI
Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): Randomised controlled trial
Philip A. Poole-Wilson,Jacobus Lubsen,Bridget-Anne Kirwan,Fred J van Dalen,Gilbert Wagener,Nicolas Danchin,Hanjörg Just,Keith A.A. Fox,Stuart J. Pocock,Tim Clayton,Michael Motro,John D. Parker,Martial G. Bourassa,Anthony M. Dart,Per Hildebrandt,Åke Hjalmarson,Johannes A. Kragten,G Peter Molhoek,J.E. Otterstad,Ricardo Seabra-Gomes,Jordi Soler-Soler,Simon Weber +21 more
TL;DR: Addition of nifedipine GITS to conventional treatment of angina pectoris has no effect on major cardiovascular event-free survival and is safe and reduces the need for coronary angiography and interventions.
Journal ArticleDOI
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management
J. Malcolm O. Arnold,Peter Liu,Catherine Demers,Paul Dorian,Nadia Giannetti,Haissam Haddad,George A. Heckman,Jonathan G. Howlett,Andrew Ignaszewski,David E. Johnstone,Philip Jong,Robert S. McKelvie,Gordon W. Moe,John D. Parker,Vivek Rao,Heather J. Ross,Errol J. Sequeira,Anna M. Svendsen,Koon K. Teo,Ross T. Tsuyuki,Michel White +20 more
TL;DR: This consensus conference to provide a comprehensive review of current knowledge and management strategies is intended to provide practical advice for specialists, family physicians, nurses, pharmacists and others who are involved in the care of heart failure patients.
Journal ArticleDOI
Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure: The VERITAS Randomized Controlled Trials
John J.V. McMurray,John R. Teerlink,Gadi Cotter,Robert C. Bourge,John G.F. Cleland,Guillaume Jondeau,Henry Krum,Marco Metra,Christopher M. O'Connor,John D. Parker,Guillermo Torre-Amione,Dirk J. van Veldhuisen,James Lewsey,Aline Frey,Maurizio Rainisio,Isaac Kobrin +15 more
TL;DR: The endothelin receptor antagonist tezosentan did not improve symptoms or clinical outcomes in patients with acute heart failure and was not associated with worse outcomes.